As neovascular (wet) AMD can progress rapidly, its early detection could reduce severe, irreversible visual loss, reducing costs induced on the public health system.*
*Extracted and translated from the October 2004 report of AETMIS (Agence gouvernementale québécoise d’évaluation des Technologies et des Modes d’Intervention en Santé)

“The telemedicine era : ‘We are watching TV while waiting to see a doctor’’”

Telemedicine provides access to quality, medical screening for AMD and all of its complications. AMD can therefore be diagnosed and treated more quickly.

Retina Labs: An alternative.
Retina Labs: Assisting the public health system by providing easy access to medical services.

Retina Labs provides easy access to medical quality screening for AMD, facilitating triaging, referral, and timely treatment.

• Patients do not have to wait long to know the satus of their eyes.
• Images of the inside of each eye are taken with specialized cameras without the need to dilate the pupils for most patients. The images are then forwarded to a medical specialist who can identify the signs and symptoms of AMD.
• These images are coupled with specialized imaging technology (OCT) that can precisely show the internal structure of the retina